News
company
year
domain
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Repertoire® Immune Medicines 04.29.2024
Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
Invaio Sciences 04.08.2024
»Æ¹ÏÊÓÆµapp Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024
03.19.2024